Oxybutynin (HCl)

Oxybutynin (HCl) is anticholinergic and antispasmodic agent. Chemically Oxybutynin (HCl) is identified as (R, S)-4-diethylamino-2-butylphenyl-cyclohexylglycolate. Oxybutynin (HCl) is used to treat urinary incontinences (both sensory and motor), and nocturnal enuresis. Oxybutynin (HCl) is prepared by chemical synthesis. Oxybutynin (HCl) is optically active and the racemate is used clinically. Oxybutynin (HCl) is not available in any combination preparations. Oxybutynin (HCl) is administered orally.

Oxybutynin (HCl) is primarily indicated in condition like Overactive Bladder

Oxybutynin (HCl) is contraindicated in conditions like Uncontrolled narrow-angel Glaucoma, Myasthenia gravis, Ulcerative colitis, Mega colon, Intestinal atony, Gastric or urinary obstruction or retention, Paralytic ileus, Severe ulcerative colitis.

The symptomatic adverse reactions produced by Oxybutynin (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fever, Palpitation, Tachycardia, Constipation, Insomnia, Diaphoresis, Nausea and vomiting, Hot flushes, Xerostomia, Dry mouth, Somnolence, Asthenia, Blurred vision, Dry eyes, Rhinitis, Fluid retention, Hot flush, Dysphagia, Frequent bowl movements, Chest discomfort, Memory impairment, Mydriasis, Hallucinations, Nasal congestion, Palpitations, Delirium, Confusion.

Alcoholic beverages may increase the drowsiness caused by oxybutynin. Before taking oxybutynin, tell the doctor about taking prescription and nonprescription drugs, because oxybutynin can affect certain medical conditions. It should be used with caution in patients with heart, liver, kidney, stomach or intestinal disease, glaucoma, colitis, intestinal obstruction, hyperthyroidism or myasthenia gravis. It should be used with caution during pregnancy or lactation. Before surgery, including dental surgery, tell the doctor or dentist about the use of the drug.

Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

5 mg (5 (5)) 12 hourly PO — Frequency may be increased upto 3 times/day if needed.

( ) — Not recommended in this age group

( ) — Not recommended in this age group

No data regarding the interactions of Oxybutynin (HCl) was found.

Syrup Store Below 40°C. Do not Freeze. Protect from Sunlight and Moisture. Tab Store Below 40°C. Protect from Sunlight and Moisture.